70.924 Methadone as Medication for Opioid Use Disorder in Community Settings MSSNY will support pilot projects on expansion of office-based methadone treatment for OUD outside OTPs when prescribed by addiction specialists and dispensed at local pharmacies with appropriate training and safeguards in place. (HOD 2023-155)
70.923 Retire Current NYS I-STOP Prescription Drug Monitoring Program and Transition to the Multistate PMP System The Medical Society of the State of New York will advocate to the New York State Department of Health for full integration access to multistate database in New York State Prescription Monitoring Program (PMP). MSSNY will also advocate for
50.983 Disclosure of Compliance issues and Creating a National Database of Joint Leadership MSSNY will urge ACCME to require organizations that apply for joint providership for accreditation of CME activities be required to disclose on its application if the activity has previously been denied accreditation and the reason for denial. MSSNY will also urge ACCME
40.995 Physician-Guided Decision Model The Medical Society of the State of New York will advocate for a physician-guided decision model where medical decisions are made between the doctor and patient. The Medical Society of the State of New York will also urge the American Medical Association (AMA) to advocate for a physician–guided decision model. (HOD
20.895 Appropriate Warning Labels and Signs on Alcoholic Beverages The Medical Society of the State of New York will continue to advocate for clear and legible warnings on all products that contain alcohol. (HOD 2023-151)
5.990 Protecting NYS Practitioners Delivering Contraception and Abortion Care MSSNY will support measures to protect practitioners licensed and residing in New York from legal or personal liability when delivering healthcare services to residents of New York State or any other state, whether in person or via telemedicine, when the services provided comply with New
5.989 Ensuring Access to Reproductive Health Services Medications The Medical Society of the State of New York will advocate and support the continuation of the Food and Drug Administration’s authority to determine whether drugs are safe and effective. The Medical Society of the State of New York will support legal efforts to ensure that mifepristone
207.948 MSSNY Best Practices Task Force The MSSNY Long-Range Planning Committee will make recommendations to the MSSNY President and Council to examine and modernize MSSNY business practices – to include creating an organizational chart and better defining the respective roles of the trustees, elected leaders, Council, House of Delegates and our administrators – to ensure
(See also Drug Dispensing, 70.000; Drugs and Medications, 75.000; Health Insurance Coverage, 120.000; Health System Reform, 130.000; Medicaid, 175.000; Peer Review, 225.000) 195.911 Care Management and Social Workers MSSNY will advocate for legislation that requires private insurers, Medicaid Managed Care Plans, and Medicare Advantage Plans to have both care managers and social workers assigned
125.989 Breast Cancer Screening/Clinical Breast Exam Coverage The Medical Society of the State of New York (MSSNY) will advocate for Medicare coverage of clinical breast exams for female and at-risk male patients during the Medicare Annual Wellness Visit (AWV) and Subsequent Annual Wellness Visit appointments. A copy of this resolution will be transmitted to the
